Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ankit Mahadevia currently holds 703,294 shares of Spero Therapeutics, Inc. (SPRO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ankit Mahadevia has been a net seller of SPRO stock. They have purchased $0 and sold $985.1K worth of shares.
Ankit Mahadevia's most recent insider trade was on Aug 28, 2025, when they sold 6,572 shares at $1.97 per share.
Ankit Mahadevia serves as Executive at Spero Therapeutics, Inc. (SPRO). They have executed 46 insider transactions totaling $985.1K over their tenure at the company.
Ankit Mahadevia holds the position of Executive at Spero Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Ankit Mahadevia has shown a selling trading pattern, with $0 in total purchases and $985.1K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Ankit Mahadevia was on Oct 13, 2020, when they sold $205.2K worth of SPRO shares. This transaction involved 14,367 shares at $14.28 per share.
Ankit Mahadevia currently owns 703,294 shares of Spero Therapeutics, Inc. (SPRO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ankit Mahadevia's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ankit Mahadevia has 46 Form 4 filings on record as an insider at Spero Therapeutics, Inc..
Set alerts for Ankit Mahadevia and 40,000+ other insiders.